Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Обзорная статья

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges

Ander Saenz‐AntoñanzasCellular Oncology group, Biodonostia Health Research Institute, E-20014 San Sebastian, SpainJaione Auzmendi-IriarteCellular Oncology group, Biodonostia Health Research Institute, E-20014 San Sebastian, SpainEstefanía Carrasco‐GarcíaCIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), 28029 Madrid, SpainLeire Moreno‐CugnonCellular Oncology group, Biodonostia Health Research Institute, E-20014 San Sebastian, SpainIrune RuizCIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), 28029 Madrid, SpainJorge VillanúaCellular Oncology group, Biodonostia Health Research Institute, E-20014 San Sebastian, SpainLarraitz EgañaCellular Oncology group, Biodonostia Health Research Institute, E-20014 San Sebastian, SpainDavid OtaeguiMultiple Sclerosis group, Biodonostia Health Research Institute, 20014 San Sebastian, SpainNicolàs SamprónCIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), 28029 Madrid, SpainAnder MatheuCIBER de Fragilidad y Envejecimiento Saludable (CIBERfes), 28029 Madrid, Spain
2019en
ABI

Аннотация

Liquid biopsy represents a minimally invasive procedure that can provide similar information from body fluids to what is usually obtained from a tissue biopsy sample. Its implementation in the clinical setting might significantly renew the field of medical oncology, facilitating the introduction of the concepts of precision medicine and patient-tailored therapies. These advances may be useful in the diagnosis of brain tumors that currently require surgery for tissue collection, or to perform genetic tumor profiling for disease classification and guidance of therapy. In this review, we will summarize the most recent advances and putative applications of liquid biopsy in glioblastoma, the most common and malignant adult brain tumor. Moreover, we will discuss the remaining challenges and hurdles in terms of technology and biology for its clinical application.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0